Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Ethics Subcommittee

Executive Summary

Ethics of a National Institutes of Health-supported protocol on leuprolide testing for puberty disorders to be reviewed by FDA's Pediatric Ethics Subcommittee Nov. 15. The protocol was rejected by University of Chicago Hospitals' Institutional Review Board because of risks from leuprolide (TAP's Lupron) to control subjects, FDA says in Oct. 7 1Federal Register notice calling for comments on the protocol. The meeting will be held at the Hilton in Gaithersburg, Md. beginning at 8:30 a.m...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS046413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel